Skip to content

Clinical trials

Not yet recruiting Lymphoma, Mantle-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Status: Not yet recruiting Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20242
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing InnoCare Pharma Tech Co., Ltd.1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Dalian Medical University1
Henan Cancer Hospital1
Peking University Cancer Hospital & Institute1
Shanxi Province Cancer Hospital1
Tianjin Medical University Cancer Institute and Hospital1
TransThera Sciences (Nanjing), Inc.1
Zhengzhou University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell9
Lymphoma2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Follicular2
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell1
Lymphoma, Large B-Cell, Diffuse1
Recurrence1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.